Effect of Vatapallava (Tender leaves of Ficus benghalensis Linn.) In Mukhadushika (Acne vulgaris)

"CLINICAL EVALUATION OF VATAPALLAVA( TENDER LEAF OF Ficus benghalensis,LINN.) IN MUKHADUSHIKA( ACNE VULGARIS)"

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/08/009299

Enrollment

Registered

2017-08-08

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patient of both sexes aged 12- 30years with acne vulgaris

Interventions

Intervention1: POWDER OF VATAPALLAVA. Lepa (Paste) of vatapallava (Tender leaves of Ficus benghalensis Linn.): Powdered drug weighing 15 g were dispensed in zip lock covers to External application for

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient of both sexes aged 12- 30years with acne vulgaris

Exclusion criteria

Exclusion criteria: Pregnant & lactating women. Known patient with PCOD. Known patients on medication for chronic illness. Known patients they are contraindicated to mukhalepa. Known drug induced acne. Known patient with inflammatory cyst and nodule over face. Known patient with other infective& inflammatory condition on face.

Design outcomes

Primary

Measure	Time frame
Changes in number of comedones, papule and pustules counted through Global acne Grading systemTimepoint: Assessment will be on 0th day, 15th day and 23rd day.	—

Secondary

Measure	Time frame
Changes in symptoms like vedana (pain), sotha (swelling), srava (oozing) and vivarnatha (discolouration) of pidaka (pimple).Timepoint: Assessment will be on 0th day, 15th day and 23rd day.	—

Countries

India

Contacts

Public ContactParvathy C A

Govt. Ayurveda College, Thiruvanathapuram

drdeepasathi@hotmail.com9446171568

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026